CGH

Researchers who set out to compare the ability of SNP and comparative genomic hybridization microarray platforms to detect copy number variation in autusm spectrum disorder managed to identify 16 genes that hadn't been associated with ASD before.

CHICAGO — Cancer Genetics will later this year expand its menu of array-based tests to include assays for informing treatment of patients with diffuse large B-cell lymphoma and renal cell carcinoma.

By Justin Petrone
ArrayGenomics recently began selling a comparative genomic hybridization array that it claims can be used to diagnose, grade, and stage bladder cancer based on DNA extracted from urine.

This article has been updated to include comments from Roche. By Justin Petrone

This story was originally posted on Nov. 17.
By Justin Petrone

By Justin Petrone
Growing demand for arrays designed to detect tumor copy-number changes is enticing more chip manufacturers to offer tools tailor-made for cancer research.

Roche NimbleGen has certified the University of Iowa's Roy J. Carver Center for Genomics to offer microarray services on its platform, Roche said last week.

The Madrid-based genetic diagnostics center, which is authorized by Madrid's health department and is accredited by the Spanish Association of Human Genetics, becomes Agilent's first certified service provider in the country.

Pages

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.